Kalsineuriini-inhibiittori pimekrolimuusin aikaansaamat histologiset muutokset valkojäkälän paranemisvaiheessa

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2007-000363-20-FI

Enrollment

Registered

2007-01-30

Start date

2007-05-03

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

valkojäkälä (lichen slerosus) MedDRA version: 9.1 Level: LLT Classification code 10024434 Term: Lichen sclerosus

Interventions

Trade Name: Elidel Pharmaceutical Form: INN or Proposed INN: pimekrolimuusi Concentration unit: % percent Concentration type: equal Concentration number: 1-

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026